If you took Zantac and are concerned that it gave you kidney or bladder cancer, and you are a non-smoker, please contact us at [email protected] or 800-776-6044 to learn more about your legal rights.
The U.S. Food and Drug Administration (“FDA”) announced recently that it is investigating Zantac and other products containing ranitidine to assess levels of a carcinogenic chemical known as N-nitrosodimethylamine or “NDMA.” An independent lab notified the FDA that Zantac and other products with ranitidine contained up to 3,000 times the designated daily intake limit of NDMA.
The link between NDMA and cancer has been known since the 1980s, but this information was concealed from the millions of people who take Zantac every day for heartburn, ulcers, acid reflux, and other issues.
If you are one of those people and you now have kidney or bladder cancer, and you are not a smoker, please contact Keller Rohrback at [email protected] or 800-776-6044 to learn more about your potential legal rights.
For more details on this case, click here.
About Keller Rohrback L.L.P.
Keller Rohrback is a leader in representing consumers who have had their safety compromised by defective products. With offices in Seattle, Phoenix, New York, Missoula, Oakland, and Santa Barbara, our firm serves as lead and co-lead counsel in class actions throughout the country. Our Complex Litigation Group is proud to offer its expertise to clients nationwide, and our trial lawyers have obtained judgments and settlements in excess of $23.25 billion.
Attorney Advertising. Prior results do not guarantee a similar outcome. Not licensed to practice law in all states. Please refer to krcomplexlit.com for details.
CONTACT US: